What the six lenses say about ORCHPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How ORCHPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | -0.3pp | -1.2pp | -1.6pp | +9.6pp | +89.0pp | +38.0pp |
Nifty 500 Broad-market baseline | -0.4pp | -1.2pp | -2.6pp | +8.0pp | +83.2pp | +32.8pp |
Sector Own-sector index | — | — | -5.5pp | +1.9pp | +70.1pp | +12.0pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
ORCHPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
ORCHPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 244 | 223 | 217 | 237 | 173 | 194 | 207 | 238 |
| ↳ change QoQ | — | -8.9% | -2.4% | +9.0% | -27.0% | +12.1% | +6.7% | +15.0% |
| EBITDA (₹cr) | 40 | 38 | 35 | 28 | 14 | -1 | 2 | 27 |
| EBITDA margin | 16.4% | 17.0% | 16.0% | 11.8% | 8.1% | -0.5% | 1.0% | 11.3% |
| PAT (₹cr) | 29 | 27 | 21 | 22 | 15 | -6 | -13 | 24 |
| ↳ change QoQ | — | -7.2% | -23.7% | +5.9% | -31.8% | -140.0% | -116.7% | +284.6% |
| Net margin | 12.0% | 12.2% | 9.6% | 9.3% | 8.7% | -3.1% | -6.3% | 10.1% |
| EPS (₹) | 5.79 | 5.37 | 4.10 | 4.39 | 2.94 | -1.13 | -2.49 | 4.69 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding ORCHPHARMA (9)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Quant Small Cap Gr | 1.00% | 34,069 | |
| Kotak Multi Asset Allocation Reg Gr | 0.63% | 14,770 | |
| UTI Small Cap Reg Gr | 0.82% | 5,263 | |
| Kotak Consumption Reg Gr | 1.60% | 1,759 | |
| PGIM India Small Cap Reg Gr | 0.83% | 1,674 | |
| UTI Healthcare Reg Gr | 0.73% | 1,371 | |
| Kotak Healthcare Reg Gr | 1.88% | 682 | |
| Bandhan Healthcare Reg Gr | 1.70% | 319 | |
| PGIM India Healthcare Reg Gr | 0.91% | 112 |
ETFs holding ORCHPHARMA (0)
No tracked ETF holds ORCHPHARMA ≥0.5%.